The DEA is currently reviewing a petition to increase the regulatory controls on hydrocodone combination products from schedule III to schedule II of the Controlled Substances Act (CSA).
Adverstisement
- Tagsacetone amnesia amphetamines cocaine codeine confusion DEA dependence depressant diarrhea drug abuse ecstasy ephedrine ethyl ether hallucinations hallucinogens heroin hydrochloric acid Inhalants laws loss of appetite marijuana methamphetamine methyl ethyl ketone morphine naloxone narcotics nausea non-controlled opium oxycodone phenylpropanolamine potassium permanganate prescription pseudoephedrine Rohypnol schizophrenia steroids stimulants sulfuric acid sweating thebaine tobacco trafficking tremors
-
Disclaimer
-
The information on this site is provided for informational purposes only, and should not be substituted for Medical Advice, Diagnosis or Treatment provided by a qualified health care professional or provider. It should not be construed to indicate that use of the drug is safe, appropriate, or effective for you. Consult your healthcare professional before using this drug. The products mentioned on this site are trademarks of their respective owners and are not owned by nor affiliated with DrugpediaOnline.com, or any of its affiliated companies. The display and use of drug information on this site is subject to express terms of use. By continuing to view drug information, you agree to abide by such terms of use.
-
-
- Recent Posts
- Archives